The lack of effect shouldn’t detract from MINT, which showed a strong trend toward benefit with liberal blood transfusion.

A study led by biomedical scientists at the University of California, Riverside School of Medicine shows how a genetic ...

Patients with myelodysplastic syndrome (MDS) who received luspatercept showed greater hemoglobin gains and transfusion ...

Patients with diabetic kidney disease (DKD) and anemia have no worse, and possibly better, cardiovascular outcomes from finerenone treatment.

Keros Therapeutics, Inc. (“Keros”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and ...

Larotrectinib is a highly selective and central nervous system-active TRK inhibitor, approved for adult and pediatric ...

Zanubrutinib showed long-term efficacy in patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL ...

Zejula with Zytiga and prednisone delayed cancer growth and symptoms in patients with castration-sensitive prostate cancer ...

The study, conducted across multiple centers in Japan and published in Advances in Therapy, was led by Dr. Osamu Wada-Hiraike ...

Updated, longer-term results from the COMMANDS trial show a promising trend toward improved overall survival with ...

In addition, mirvetuximab soravtansine (Elahere) was the first targeted therapy to demonstrate an improvement in OS in ...

A study led by biomedical scientists at the University of California, Riverside School of Medicine shows how a genetic ...